CareRx
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of CareRx generated cash of $27,375,000, which is more than the previous year. Cash used in financing activities reached the amount of -$36,403,000 last year. Net change in cash is therefore -$21,342,000.
Cash Flow
| 2014 | 19.71M | 16.92M | -36.40M |
|---|---|---|---|
| 2015 | 29.44M | 5.92M | -20.73M |
| 2016 | 1.7M | 204.25M | -220.83M |
| 2017 | 16.07M | -8.37M | -7.69M |
| 2018 | 6.59M | -6.27M | -315K |
| 2019 | 6.35M | 33.82M | -40.12M |
| 2020 | 229K | -4.17M | 23.50M |
| 2021 | 7.26M | -93.17M | 101.91M |
| 2022 | 22.33M | -16.59M | -12.98M |
| 2023 | 27.37M | -12.31M | -36.40M |
CRRX.TO Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 29.05M | 35.62M | 19.62M | 61K | 1.4M | 0 | 3M | 14.88M | 237K | 0 |
Operating activities | ||||||||||
Net income | -5.40M | -34.35M | -22.73M | -18.26M | -29.30M | -31.09M | 2.27M | -19.80M | 45.86M | -57.20M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 19.97M | 20.06M | 15.39M | 11.45M | 9.32M | 9.64M | 9.52M | 11.78M | 27.75M | 29.71M |
Stock-based compensation expense | 1.47M | 4.56M | 2.66M | 2.52M | 2.29M | 0 | 938K | 790K | 1.26M | 1.81M |
| Deferred income tax benefit | 1.47M | 4.56M | 2.66M | 2.52M | 2.29M | 0 | 938K | 790K | 1.26M | 1.81M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 1.46M | 1.51M | -11.71M | 2.53M | -1.02M | 1.96M | 1.42M | -2.58M | -850K | -2.54M |
Inventories | 648K | -1.99M | -2.83M | 492K | -525K | 1.27M | 265K | -576K | 513K | -1.09M |
Accounts payable | -181K | 816K | 14.99M | -2.76M | 1.15M | -4.41M | -2.46M | -11.34M | 14.65M | 7.66M |
Cash generated by operating activities | 27.37M | 22.33M | 7.26M | 229K | 6.35M | 6.59M | 16.07M | 1.7M | 29.44M | 19.71M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | -950K | -1M | 0 | -236.89M | 0 |
Investments In Property Plant And Equipment | -4.72M | -13.61M | -7.11M | -1.95M | -3.49M | -4.45M | -7.65M | -2.94M | -5.62M | -7.74M |
Acquisitions Net | -3.65M | -2.98M | -86.12M | -3.61M | 37.28M | -921K | 181K | -16.97M | 221.94M | 60.73M |
Cash generated by investing activities | -12.31M | -16.59M | -93.17M | -4.17M | 33.82M | -6.27M | -8.37M | 204.25M | 5.92M | 16.92M |
Financing activities | ||||||||||
Common Stock Issued | 14.67M | 1.00M | 80.85M | 10.18M | 18.73M | 460K | 140K | 0 | 0 | 2.03M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | -56K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -39.82M | -5.28M | -30.63M | -18.98M | -51.76M | -6.93M | -4.41M | -219.71M | 5.91M | -2.86M |
Cash used in financing activities | -36.40M | -12.98M | 101.91M | 23.50M | -40.12M | -315K | -7.69M | -220.83M | -20.73M | -36.40M |
Net Change In Cash | -21.34M | -7.25M | 16.00M | 19.56M | -1.33M | 0 | 0 | -11.88M | 14.64M | 237K |
Cash at end of period | 7.70M | 28.37M | 35.62M | 19.62M | 61K | 0 | 3M | 3M | 14.88M | 237K |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |